46 related articles for article (PubMed ID: 33461196)
1. Tissue Expression of Androgen Receptor Splice Variant 7 at Radical Prostatectomy Predicts Risk of Progression in Untreated Nonmetastatic Prostate Cancer.
Sciarra A; Maggi M; Salciccia S; Nicolai A; Tortorella E; Giantulli S; Magliocca FM; Silvestri I; Taglieri L; Cattarino S; Scarpa S
Oncology; 2021; 99(4):251-255. PubMed ID: 33461196
[TBL] [Abstract][Full Text] [Related]
2. NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimers.
Guzman J; Weigelt K; Neumann A; Tripal P; Schmid B; Winter Z; Palmisano R; Culig Z; Cronauer MV; Muschler P; Wullich B; Taubert H; Wach S
BMC Cancer; 2024 Mar; 24(1):346. PubMed ID: 38500100
[TBL] [Abstract][Full Text] [Related]
3. Constitutively active AR-V7 plays an essential role in the development and progression of castration-resistant prostate cancer.
Qu Y; Dai B; Ye D; Kong Y; Chang K; Jia Z; Yang X; Zhang H; Zhu Y; Shi G
Sci Rep; 2015 Jan; 5():7654. PubMed ID: 25563505
[TBL] [Abstract][Full Text] [Related]
4. NF-κB and androgen receptor variant expression correlate with human BPH progression.
Austin DC; Strand DW; Love HL; Franco OE; Jang A; Grabowska MM; Miller NL; Hameed O; Clark PE; Fowke JH; Matusik RJ; Jin RJ; Hayward SW
Prostate; 2016 Apr; 76(5):491-511. PubMed ID: 26709083
[TBL] [Abstract][Full Text] [Related]
5. AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer.
Kim S; Au CC; Jamalruddin MAB; Abou-Ghali NE; Mukhtar E; Portella L; Berger A; Worroll D; Vatsa P; Rickman DS; Nanus DM; Giannakakou P
Elife; 2022 Jul; 11():. PubMed ID: 35848798
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression.
Pimenta R; Malulf FC; Romão P; Caetano GVB; da Silva KS; Ghazarian V; Dos Santos GA; Guimarães V; Silva IA; de Camargo JA; Recuero S; Melão BVLA; Antunes AA; Srougi M; Nahas W; Leite KRM; Reis ST
J Cancer Res Clin Oncol; 2024 Feb; 150(2):70. PubMed ID: 38305916
[TBL] [Abstract][Full Text] [Related]
7. Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma: Diagnostic and therapeutic implications.
Zhao P; Zhu Y; Cheng L; Luo J
Asian J Urol; 2019 Jan; 6(1):109-113. PubMed ID: 30775254
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor splice variant 7 (AR-V7) and drug efficacy in castration-resistant prostate cancer: Biomarker for treatment selection exclusion or inclusion?
Leibrand CR; Price DK; Figg WD
Cancer Biol Ther; 2016 May; 17(5):467-9. PubMed ID: 26985596
[TBL] [Abstract][Full Text] [Related]
9. Novel Androgen Receptor Splice Variant 7 in Gynecologic Tumors.
Wang L; Vasudevaraja V; Tran I; Sukhadia P; Reuter VE; Abu-Rustum NR; Rubinstein MM; Gopalan A; Ross D; Snuderl M; Chiang S
Int J Gynecol Pathol; 2024 May; ():. PubMed ID: 38833720
[TBL] [Abstract][Full Text] [Related]
10. Trends in estrogen and progesterone receptors in prostate cancer: a bibliometric analysis.
Liao W; Sui X; Hou G; Yang M; Lin Y; Lu J; Yang Q
Front Oncol; 2023; 13():1111296. PubMed ID: 37361598
[TBL] [Abstract][Full Text] [Related]
11. Research hotspots of prostate cancer at the international conferences on urology in 2022.
Yi J; Li J; Xie L
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 52(2):178-184. PubMed ID: 37283102
[TBL] [Abstract][Full Text] [Related]
12. AR and PI3K/AKT in Prostate Cancer: A Tale of Two Interconnected Pathways.
Tortorella E; Giantulli S; Sciarra A; Silvestri I
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768370
[TBL] [Abstract][Full Text] [Related]
13. The involvement of high succinylation modification in the development of prostate cancer.
Zhang Z; Chen Y; Fang L; Zhao J; Deng S
Front Oncol; 2022; 12():1034605. PubMed ID: 36387072
[TBL] [Abstract][Full Text] [Related]
14. The Crucial Role of AR-V7 in Enzalutamide-Resistance of Castration-Resistant Prostate Cancer.
Zheng Z; Li J; Liu Y; Shi Z; Xuan Z; Yang K; Xu C; Bai Y; Fu M; Xiao Q; Sun H; Shao C
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230800
[TBL] [Abstract][Full Text] [Related]
15. Radiomics in prostate cancer: an up-to-date review.
Ferro M; de Cobelli O; Musi G; Del Giudice F; Carrieri G; Busetto GM; Falagario UG; Sciarra A; Maggi M; Crocetto F; Barone B; Caputo VF; Marchioni M; Lucarelli G; Imbimbo C; Mistretta FA; Luzzago S; Vartolomei MD; Cormio L; Autorino R; Tătaru OS
Ther Adv Urol; 2022; 14():17562872221109020. PubMed ID: 35814914
[TBL] [Abstract][Full Text] [Related]
16. Citric Acid as a Potential Prostate Cancer Biomarker Determined in Various Biological Samples.
Buszewska-Forajta M; Monedeiro F; Gołębiowski A; Adamczyk P; Buszewski B
Metabolites; 2022 Mar; 12(3):. PubMed ID: 35323711
[TBL] [Abstract][Full Text] [Related]
17. Androgen-Dependent Prostate Cancer Cells Reprogram Their Metabolic Signature upon GLUT1 Upregulation by Manganese Superoxide Dismutase.
Quiros-Gonzalez I; Gonzalez-Menendez P; Mayo JC; Hevia D; Artime-Naveda F; Fernandez-Vega S; Fernandez-Fernandez M; Rodriguez-Gonzalez P; Garcia-Alonso JI; Sainz RM
Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204196
[TBL] [Abstract][Full Text] [Related]
18. Influence of operative time and blood loss on surgical margins and functional outcomes for laparoscopic versus robotic-assisted radical prostatectomy: a prospective analysis.
Salciccia S; Rosati D; Viscuso P; Canale V; Scarrone E; Frisenda M; Catuzzi R; Moriconi M; Asero V; Signore S; De Dominicis M; Emiliozzi P; Carbone A; Pastore AL; Fuschi A; Di Pierro GB; Gentilucci A; Cattarino S; Mariotti G; Busetto GM; Ferro M; De Berardinis E; Ricciuti GP; Panebianco V; Magliocca FM; Del Giudice F; Maggi M; Sciarra A
Cent European J Urol; 2021; 74(4):503-515. PubMed ID: 35083069
[TBL] [Abstract][Full Text] [Related]
19. SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study.
Maggi M; Del Giudice F; Falagario UG; Cocci A; Russo GI; Di Mauro M; Sepe GS; Galasso F; Leonardi R; Iacona G; Carroll PR; Cooperberg MR; Porreca A; Ferro M; Lucarelli G; Terracciano D; Cormio L; Carrieri G; De Berardinis E; Sciarra A; Busetto GM
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922626
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
